Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmaforte

Full company profile

uuid000b8n6

Namestring
Pharmaforte
Legal namestring
Pharmaforte Malaysia Sdn. Bhd.
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Pharmaforte is a privately held pharmaceutical and medical device distribution group operating across Malaysia and Singapore through two wholly-owned entities, Pharmaforte Malaysia Sdn. Bhd. (headquartered in Petaling Jaya) and Pharmaforte Singapore Pte Ltd (headquartered in Singapore). Founded in 1995, the company functions as the in-market distribution partner for more than 30 international pharmaceutical and medical device principals, providing warehousing, inventory management, logistics, and field sales coverage to approximately 11,000 hospitals, clinics, and pharmacies in both countries.

The company's service portfolio spans pharmaceutical distribution, medical device distribution, warehousing and cold-chain logistics for temperature-sensitive products (vaccines and in-vitro diagnostics), and principal representation. The technology base is conventional: no proprietary software, no AI systems, and no disclosed digital platform are mentioned; the offering rests on physical infrastructure, regulatory certifications (GDPMD in Malaysia, TÜV SÜD SS620:2016 in Singapore, BizSafe Level 3, and a 2023 nuclear medicine transportation license), and a direct field sales force of 70–80 representatives covering more cities and towns across the territory than several multinational pharmaceutical competitors.

The business model is a B2B transaction-fee distribution arrangement: Pharmaforte purchases from international principals and resells to healthcare institutions, with revenue mechanics driven by negotiated pricing, product mix, and volume throughput. The company generates no publicly disclosed revenue and operates without external venture capital or private equity backing per the ownership commentary, though a 2021 funding event involving Advantage Partners is listed. Customer concentration risk is structurally low given the 11,000-outlet long-tail reach, while principal-side dependency is partially opaque given undisclosed individual manufacturer contribution.

Short descriptiontext

Pharmaforte is a Singapore- and Malaysia-based pharmaceutical and medical device distributor, founded in 1995, that represents 30+ international principals and serves 11,000 hospitals, clinics, and pharmacies via an 80-person direct field sales force and certified warehousing operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, medical device distribution, healthcare logistics services, pharmaceutical warehousing, principal representation services
Industry3 codes
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAG
Vaccines & Cold-Chain Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Distribution Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Distribution
TypeTransaction Fee
Description

Distribution of pharmaceutical products and medical devices through a network of 80 sales representatives serving hospitals, clinics, and pharmacies across Malaysia and Singapore. Acts as a principal-agent for international pharmaceutical manufacturers, maintaining inventory, warehousing, logistics, and distribution capabilities.

pharmafortegroup.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharmaforte distributes quality pharmaceuticals, medical devices, vaccines, and in-vitro diagnostic devices on behalf of more than 30 international principals to roughly 11,000 hospitals, clinics, and pharmacies across Malaysia and Singapore. The offering bundles licensed import, secondary assembly, temperature-controlled warehousing, logistics, and inventory management with a direct field sales force of around 80 representatives, supported by GDPMD and TÜV SÜD certifications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pharmaforte is a pharmaceutical distribution company operating as a single unified offering rather than a platform-plus-modules architecture. The company's core business is pharmaceutical and healthcare product distribution services, encompassing warehousing and logistics, medical device distribution, and principal representation across Malaysia and Singapore. With over 30 years of operation since 1995, the company serves approximately 11,000 customers including hospitals, clinics, and pharmacies through a network of 70 sales representatives. The company represents over 30 international pharmaceutical principals and maintains facilities certified for Good Distribution Practice, handling temperature-sensitive products including vaccines and in-vitro diagnostic devices.

Product and service4 records
1Pharmaceutical Distribution Services
CategoryPharmaceutical Distribution
Description

Distribution of quality pharmaceuticals and healthcare products to hospitals, clinics, and pharmacies across Malaysia and Singapore. Serves over 11,000 customers through a direct field sales force of approximately 70–80 sales representatives acting as the in-territory agent for international pharmaceutical principals.

2Warehousing and Logistics Services
CategoryHealthcare Logistics
Description

Comprehensive warehouse and logistics services including handling, storage, distribution, and inventory management for a wide range of products. Includes temperature-controlled storage and distribution of temperature-sensitive products such as vaccines and in-vitro diagnostic devices, with facilities certified for Good Distribution Practices in both Malaysia and Singapore. Secondary assembly and import handling are included in Singapore operations.

3Medical Device Distribution
CategoryMedical Device Distribution
Description

Distribution of medical devices to hospitals, clinics, and pharmacies, maintaining quality, safety, and performance of medical devices throughout the value chain under GDPMD certification and TÜV SÜD standards. Includes licensed import, secondary assembly, distribution, and sale in Singapore.

4Principal / Manufacturer Representation Services
CategoryDistribution Agency / Channel Representation
Description

In-territory agency, distribution, and supply chain representation for international pharmaceutical and medical device manufacturers (principals) seeking to establish and expand business presence in Malaysia and Singapore. Includes warehousing, logistics, inventory management, regulatory compliance, and sales coverage through the company's sales force for principals' products, including temperature-sensitive items.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaforte represents over 30 leading international pharmaceutical and medical device manufacturers as their distribution partner in Malaysia and Singapore. Some principals have maintained relationships for over 20 years. The company provides warehousing, logistics, inventory management, and distribution services for principals' products, including temperature-sensitive items like vaccines and in-vitro diagnostic devices.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest pharmaceutical distribution companies in Asia, operating across multiple Southeast Asian markets including Malaysia and Singapore. Directly comparable in product category, customer base (hospitals/clinics/pharmacies), and distribution model, but at substantially greater scale.

TypeDirect peer
Description

Swiss-headquartered market expansion services company with a major Healthcare distribution business across Asia including Malaysia and Singapore. Comparable as a principal-agency pharmaceutical and medical device distributor serving the same customer verticals.

TypeBroad incumbent
Description

Global pharmaceutical distribution giant (formerly AmerisourceBergen) operating across multiple continents. Comparable as a pharmaceutical wholesaler with similar GDP-compliant cold-chain capabilities, though operating at vastly larger scale and broader geographic scope.

4McKesson
TypeBroad incumbent
Description

Major US-headquartered pharmaceutical distributor and healthcare services company. Operates in pharmaceutical wholesale with similar B2B distribution to pharmacies, hospitals, and clinics, though at significantly larger scale and primarily North American focus.

TypeBroad incumbent
Description

US-based pharmaceutical and medical product distributor serving hospitals, pharmacies, and healthcare providers. Comparable business model as a wholesale distributor of drugs and medical devices, though at much larger scale and concentrated in North America.

6Medipal Holdings
TypeRegional player
Description

Japanese pharmaceutical wholesaler with growing Asia-Pacific presence. Comparable as a pharmaceutical distribution business serving hospitals and pharmacies, though primarily Japan-focused with similar transaction-based revenue model.

7Alfresa Holdings
TypeRegional player
Description

Leading Japanese pharmaceutical wholesaler distributing pharmaceuticals, medical devices, and diagnostics. Comparable in product portfolio (drugs, medical devices, IVDs) and customer base, though operating predominantly in the Japanese market.

TypeRegional player
Description

Major European pharmaceutical wholesale and retail pharmacy group. Comparable as a pharmaceutical wholesaler with a transaction-fee distribution model, though geographically focused on Europe rather than Southeast Asia.

TypeRegional player
Description

China's largest pharmaceutical and healthcare products distributor with growing Asia-Pacific reach. Comparable in pharmaceutical wholesale distribution and cold-chain logistics, though dominant in the China market.

TypeEmerging player
Description

China-based pharmaceutical manufacturer and distributor with expanding Southeast Asian distribution operations. Comparable as a pharmaceutical distributor pursuing ASEAN market entry, though smaller and more regionally emerging relative to multinational incumbents.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmaforte

Pharmaceutical Distribution Servicespharmaforte.com.sg

Pharmaforte is a Singapore- and Malaysia-based pharmaceutical and medical device distributor, founded in 1995, that represents 30+ international principals and serves 11,000 hospitals, clinics, and pharmacies via an 80-person direct field sales force and certified warehousing operations.

What Pharmaforte does

Pharmaforte is a privately held pharmaceutical and medical device distribution group operating across Malaysia and Singapore through two wholly-owned entities, Pharmaforte Malaysia Sdn. Bhd. (headquartered in Petaling Jaya) and Pharmaforte Singapore Pte Ltd (headquartered in Singapore). Founded in 1995, the company functions as the in-market distribution partner for more than 30 international pharmaceutical and medical device principals, providing warehousing, inventory management, logistics, and field sales coverage to approximately 11,000 hospitals, clinics, and pharmacies in both countries.

The company's service portfolio spans pharmaceutical distribution, medical device distribution, warehousing and cold-chain logistics for temperature-sensitive products (vaccines and in-vitro diagnostics), and principal representation. The technology base is conventional: no proprietary software, no AI systems, and no disclosed digital platform are mentioned; the offering rests on physical infrastructure, regulatory certifications (GDPMD in Malaysia, TÜV SÜD SS620:2016 in Singapore, BizSafe Level 3, and a 2023 nuclear medicine transportation license), and a direct field sales force of 70–80 representatives covering more cities and towns across the territory than several multinational pharmaceutical competitors.

The business model is a B2B transaction-fee distribution arrangement: Pharmaforte purchases from international principals and resells to healthcare institutions, with revenue mechanics driven by negotiated pricing, product mix, and volume throughput. The company generates no publicly disclosed revenue and operates without external venture capital or private equity backing per the ownership commentary, though a 2021 funding event involving Advantage Partners is listed. Customer concentration risk is structurally low given the 11,000-outlet long-tail reach, while principal-side dependency is partially opaque given undisclosed individual manufacturer contribution.

Pharmaforte firmographics

Firmographics
Name
Pharmaforte
Legal name
Pharmaforte Malaysia Sdn. Bhd.
Website
https://pharmaforte.com.sg
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
11–50 employees
Short description
Pharmaforte is a Singapore- and Malaysia-based pharmaceutical and medical device distributor, founded in 1995, that represents 30+ international principals and serves 11,000 hospitals, clinics, and pharmacies via an 80-person direct field sales force and certified warehousing operations.
Ownership category
akta.pro rank

Pharmaforte industry classification

Industry
Product category
Pharmaceutical Distribution Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAIAJAD
Hospital & Health-System Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAG
Vaccines & Cold-Chain Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Pharmaceutical distribution
  • Medical device distribution
  • Healthcare logistics services
  • Pharmaceutical warehousing
  • Principal representation services

Where Pharmaforte is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices2 records

Markets served

Pharmaforte business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Distribution: Distribution of pharmaceutical products and medical devices through a network of 80 sales representatives serving hospitals, clinics, and pharmacies across Malaysia and Singapore. Acts as a principal-agent for international pharmaceutical manufacturers, maintaining inventory, warehousing, logistics, and distribution capabilities.

Go-to-market motion1 record

Distribution channels1 record

Pharmaforte product offering

Product offering

Core offering

Pharmaforte distributes quality pharmaceuticals, medical devices, vaccines, and in-vitro diagnostic devices on behalf of more than 30 international principals to roughly 11,000 hospitals, clinics, and pharmacies across Malaysia and Singapore. The offering bundles licensed import, secondary assembly, temperature-controlled warehousing, logistics, and inventory management with a direct field sales force of around 80 representatives, supported by GDPMD and TÜV SÜD certifications.

Product overview

Pharmaforte is a pharmaceutical distribution company operating as a single unified offering rather than a platform-plus-modules architecture. The company's core business is pharmaceutical and healthcare product distribution services, encompassing warehousing and logistics, medical device distribution, and principal representation across Malaysia and Singapore. With over 30 years of operation since 1995, the company serves approximately 11,000 customers including hospitals, clinics, and pharmacies through a network of 70 sales representatives. The company represents over 30 international pharmaceutical principals and maintains facilities certified for Good Distribution Practice, handling temperature-sensitive products including vaccines and in-vitro diagnostic devices.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Distribution Services Distribution of quality pharmaceuticals and healthcare products to hospitals, clinics, and pharmacies across Malaysia and Singapore. Serves over 11,000 customers through a direct field sales force of approximately 70–80 sales representatives acting as the in-territory agent for international pharmaceutical principals.
  • Warehousing and Logistics Services Comprehensive warehouse and logistics services including handling, storage, distribution, and inventory management for a wide range of products. Includes temperature-controlled storage and distribution of temperature-sensitive products such as vaccines and in-vitro diagnostic devices, with facilities certified for Good Distribution Practices in both Malaysia and Singapore. Secondary assembly and import handling are included in Singapore operations.
  • Medical Device Distribution Distribution of medical devices to hospitals, clinics, and pharmacies, maintaining quality, safety, and performance of medical devices throughout the value chain under GDPMD certification and TÜV SÜD standards. Includes licensed import, secondary assembly, distribution, and sale in Singapore.
  • Principal / Manufacturer Representation Services In-territory agency, distribution, and supply chain representation for international pharmaceutical and medical device manufacturers (principals) seeking to establish and expand business presence in Malaysia and Singapore. Includes warehousing, logistics, inventory management, regulatory compliance, and sales coverage through the company's sales force for principals' products, including temperature-sensitive items.

Companies that use Pharmaforte

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Pharmaforte technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharmaforte partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 30+ International Pharmaceutical PrincipalscoreChannel Partner/ Reseller/ DistributorPharmaforte represents over 30 leading international pharmaceutical and medical device manufacturers as their distribution partner in Malaysia and Singapore. Some principals have maintained relationships for over 20 years. The company provides warehousing, logistics, inventory management, and distribution services for principals' products, including temperature-sensitive items like vaccines and in-vitro diagnostic devices.

Scale indicators6 records

Recent moves4 records

Expansion highlights4 records

Pharmaforte competitors and assessment

Company assessment

Direct peers

  • Zuellig Pharma: One of the largest pharmaceutical distribution companies in Asia, operating across multiple Southeast Asian markets including Malaysia and Singapore. Directly comparable in product category, customer base (hospitals/clinics/pharmacies), and distribution model, but at substantially greater scale.
  • DKSH: Swiss-headquartered market expansion services company with a major Healthcare distribution business across Asia including Malaysia and Singapore. Comparable as a principal-agency pharmaceutical and medical device distributor serving the same customer verticals.

Broad incumbents

  • Cencora: Global pharmaceutical distribution giant (formerly AmerisourceBergen) operating across multiple continents. Comparable as a pharmaceutical wholesaler with similar GDP-compliant cold-chain capabilities, though operating at vastly larger scale and broader geographic scope.
  • McKesson: Major US-headquartered pharmaceutical distributor and healthcare services company. Operates in pharmaceutical wholesale with similar B2B distribution to pharmacies, hospitals, and clinics, though at significantly larger scale and primarily North American focus.
  • Cardinal Health: US-based pharmaceutical and medical product distributor serving hospitals, pharmacies, and healthcare providers. Comparable business model as a wholesale distributor of drugs and medical devices, though at much larger scale and concentrated in North America.

Regional players

  • Medipal Holdings: Japanese pharmaceutical wholesaler with growing Asia-Pacific presence. Comparable as a pharmaceutical distribution business serving hospitals and pharmacies, though primarily Japan-focused with similar transaction-based revenue model.
  • Alfresa Holdings: Leading Japanese pharmaceutical wholesaler distributing pharmaceuticals, medical devices, and diagnostics. Comparable in product portfolio (drugs, medical devices, IVDs) and customer base, though operating predominantly in the Japanese market.
  • Phoenix Group: Major European pharmaceutical wholesale and retail pharmacy group. Comparable as a pharmaceutical wholesaler with a transaction-fee distribution model, though geographically focused on Europe rather than Southeast Asia.
  • Sinopharm Group: China's largest pharmaceutical and healthcare products distributor with growing Asia-Pacific reach. Comparable in pharmaceutical wholesale distribution and cold-chain logistics, though dominant in the China market.

Emerging players

  • Yiling Pharmaceutical: China-based pharmaceutical manufacturer and distributor with expanding Southeast Asian distribution operations. Comparable as a pharmaceutical distributor pursuing ASEAN market entry, though smaller and more regionally emerging relative to multinational incumbents.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Pharmaforte social profiles

Digital presence

Pharmaforte compliance and trust

Trust signal

Compliance8 records

Pharmaforte financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmaforte leadership team

Management profile

Number of profiles

Pharmaforte subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Pharmaforte funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmaforte M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaforte

What does Pharmaforte do?

Pharmaforte distributes quality pharmaceuticals, medical devices, vaccines, and in-vitro diagnostic devices on behalf of more than 30 international principals to roughly 11,000 hospitals, clinics, and pharmacies across Malaysia and Singapore. The offering bundles licensed import, secondary assembly, temperature-controlled warehousing, logistics, and inventory management with a direct field sales force of around 80 representatives, supported by GDPMD and TÜV SÜD certifications.

Is Pharmaforte a public or private company?

Pharmaforte is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pharmaforte founded?

Pharmaforte was founded in 1995. It employs 11 to 50 people.

Where is Pharmaforte based?

Pharmaforte is headquartered in Singapore, Singapore, in the Asia region.

How does Pharmaforte make money?

One revenue line is on record: pharmaceutical Distribution.

Who are Pharmaforte's main competitors?

Direct peers on record are Zuellig Pharma and DKSH. Broad incumbents are Cencora, McKesson and Cardinal Health. Regional players are Medipal Holdings, Alfresa Holdings, Phoenix Group and Sinopharm Group. Yiling Pharmaceutical is listed as an emerging player.

Does Pharmaforte have an API?

No public API is recorded for Pharmaforte.

What industry is Pharmaforte in?

Pharmaforte's product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales